Aggressive lymphoma: Low doses of approved drug switches on pathway that allows chemotherapy to kill cancer
Friday, August 16, 2013 - 12:30
in Health & Medicine
Patients with an aggressive lymphoma that often relapses and kills within two years experienced a remission of their cancer and stayed disease-free as long as 28 months after taking a commercially-available drug that made chemotherapy more effective.